Viewing nowErosuva Tablet 20 mg (Rosuvastatin Calcium (Unrefined))
Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Jungheon Pharmaceutical Co., Ltd.

MFDS item code 201400401 · Approved 2014.01.29 · Insurance code 053300630
Treatment for hypercholesterolemia (primary, familial) and reduction of cardiovascular disease risk
This medication is very useful for patients with hypercholesterolemia and hyperlipidemia. It is used primarily for primary hypercholesterolemia or familial hypercholesterolemia that is not controlled by diet and exercise, as well as combined hyperlipidemia. Additionally, it is used as an adjunct when patients with homozygous familial hypercholesterolemia are on dietary or other treatments. This medicine helps lower total cholesterol and LDL cholesterol levels, thereby slowing the progression of atherosclerosis. It also assists in dietary management for young patients with high LDL cholesterol levels or cardiovascular disease risk factors. Furthermore, it is used in treating primary dysbetalipoproteinemia and is effective in reducing the risk of stroke, myocardial infarction, and revascularization in high-risk patients. This medication is used for cholesterol management and reducing cardiovascular disease risk.
Administer once daily at any time regardless of meals. The initial dose is 5 mg, and the maintenance dose is 10 mg, which most patients are adjusted to at this dosage. The maintenance dose may be adjusted appropriately depending on LDL cholesterol levels and patient response, with an increase up to a maximum of 20 mg possible at intervals of 4 weeks or more.
For pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia, the dosage is 5 mg to 20 mg once daily. There is no clinical data for doses exceeding 20 mg.
This medication should not be used in certain patients. For instance, it is contraindicated in patients with allergies to the components of this drug, severely impaired liver function, muscular diseases, severely reduced kidney function, and in women who are pregnant or breastfeeding. Additionally, high-dose administration is prohibited in patients at risk of myopathy. This medication contains lactose, so caution is needed for patients with lactose intolerance. Patients with a history of liver disease or those who consume alcohol heavily should have liver function tests performed periodically while using this medication. If symptoms of myalgia or muscle weakness appear, the doctor should be informed immediately, and the medication may be discontinued if necessary. Caution is especially advised for patients with kidney disease, a history of hypothyroidism, or genetic muscle disorders due to a higher risk of muscle problems. Women who may become pregnant should use adequate contraception to avoid pregnancy, and they should discontinue use immediately if pregnancy occurs. This medication may interact with other drugs, so patients must inform their healthcare provider about any concurrent medications. There is no specific antidote for overdose, so treatment should be symptomatic, monitoring liver function and muscle enzyme levels. This medication may cause side effects such as dizziness, requiring caution when driving or operating machinery. While taking this drug, adverse reactions such as headaches, dizziness, myalgia, dyspepsia, and skin rash may occur, and patients should consult healthcare providers if symptoms worsen. Overall, this medication should be used with careful observation of liver and muscle health, and regular examinations to confirm safety are important.
Urticaria, angioedema, chest tightness, difficulty breathing, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), jaundice, hepatitis, liver failure, acute renal failure, oliguria, severe muscular weakness, ophthalmoplegia, rhabdomyolysis, immune-mediated necrotizing myopathy, severe allergic reactions, severe skin reactions, respiratory problems, liver abnormalities (jaundice), severe neurological symptoms, severe
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture ingress. The storage temperature should be maintained at room temperature between 1 degree Celsius and 30 degrees Celsius. Doing so will ensure the medication's efficacy is preserved.
Pink round film-coated tablet
Bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Jungheon Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 20.8mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Daiwoo Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Myungjin Pharmaceutical Co., Ltd.

Rosuvastatin Calcium Micronized 5.2mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.

Rosuvastatin Calcium Micronized 10.4mg
Tablet · Prescription medication
Teragen Etex Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.